[Federal Register Volume 76, Number 163 (Tuesday, August 23, 2011)]
[Notices]
[Page 52670]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-21514]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


2011 Technology Transfer Summit North America Conference

AGENCY: National Institutes of Health, Public Health Service, HHS.

ACTION: Notice of Conference.

-----------------------------------------------------------------------

SUMMARY: The NIH Office of Technology Transfer extends invitations to 
attend the 2011 Technology Transfer Summit North America Conference.

DATES: October 3-4, 2011.

ADDRESSES: NIH campus, 9000 Rockville Pike, Bethesda MD, NIH Clinical 
Center (Building 10), Masur Auditorium.

SUPPLEMENTARY INFORMATION: The NIH campus in Bethesda, MD will be the 
site for the 2011 Tech Transfer Summit North America (TTSNA), the 
leading early-stage biotech partnering, licensing, venture and 
innovation platform, co-hosted and co-sponsored by the NIH Office of 
Technology Transfer, TTS Ltd. and regional host partners such as BIO 
Maryland.
    TTSNA is one of a series of summits held within the Global Tech 
Transfer Initiative and is designed specifically to put innovators, 
early-stage SMEs and technology managers from leading universities and 
research institutes together with biotech & pharma licensing & business 
development executives, VCs, serial entrepreneurs, and leading IP 
specialists for interactive sessions relating to partnering, licensing 
& business development.
    Conference speakers for the 2011 include:

--Kathy Hudson, Deputy Director, National Institutes of Health (NIH)
--James C. Greenwood, President & CEO, BIO
--Shiv Krishnan, Director, Scouting & Partnering, Sanofi, USA
--Sanjeev Munshi, Director, Licensing and External Research, Merck & Co
--David Kaslow, Head of Vaccines Project & Pipeline Leadership, Merck & 
Co
--Ed Mascioli, Head of Orphan & Genetic Diseases Research Unit, Pfizer
--Arthur Tzianabos, Vice President of Research, HGT Division, Shire
--Steve Groft, Director, Office of Rare Diseases Research, NIH
--Phil Ross, Managing Director, Healthcare, JPMorgan
--Maarten deJong, Managing Director, Barclays Capital
--Andrew Robertson, Chief Policy Officer, BIO Ventures for Global 
Health
--Orin Herskowitz, Executive Director & Vice President, Intellectual 
Property Technology Transfer, Columbia Technology Ventures
--Erik Lium, Assistant Vice Chancellor of Research, UCSF
--Brian Kelly, Director, Technology, Enterprise & Commercialisation, 
Weill Cornell Medical College
--Daniel Perez, Partner, Bay City Capital
--Hubert Birner, Partner, TVM Capital
--Glen Steinbach, COO, Johns Hopkins Technology Transfer
--Markus Goebel, Managing Director, Novartis Venture Fund

    The Summit will strive to induce interactive debate, deliberation 
and discussion, networking and business over the 2-day period with the 
leaders in the sector. The Summit conference will be further enhanced 
by the TTS Initiative Business Social Network, an online business-
networking platform powered by JuJaMa. The Network is a communication 
tool for business that will allow the posting of profiles and 
technology offers; the searching of other participants by category, by 
technology or licensing offer; and the setting up of meetings prior to, 
during and after the Summit. Total participation numbers for this 
conference will be strictly limited to ensure the ideal environment for 
real discussion and business.

FOR FURTHER INFORMATION CONTACT: More details about the conference 
including registration information and the conference agenda can be 
found by contacting Tech Transfer Summit North America (http://www.techtransfersummit.com/northamerica2011). Attendees may also enter 
the Partner Code ``NIH11'' to register with a 10% reduction. For 
information about sign language interpretation or accommodation for 
disabilities, please contact Sharon Fields at telephone 301-594-7700 or 
<a href="/cdn-cgi/l/email-protection#680e010d040c1b1b0028070c46060100460f071e"><span class="__cf_email__" data-cfemail="593f303c353d2a2a3119363d77373031773e362f">[email protected]</span></a>.

     Dated: August 16, 2011.
Steven M. Ferguson,
Deputy Director, Licensing & Entrepreneurship, Office of Technology 
Transfer, National Institutes of Health.
[FR Doc. 2011-21514 Filed 8-22-11; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>